Correção de comunicação interatrial com cirurgia minimamente invasiva em pacientes pediátricos Minimally invasive surgical correction of interatrial communication in pediatric patients

Visando um melhor resultado estético pode-se optar por técnicas minimamente invasivas na correção cirúrgica das cardiopatias congênitas. Entre os acessos utilizados realizamos a esternotomia parcial em 20 pacientes pediátricos para correção de comunicação interatrial (CIA). Após análise deste grupo de pacientes concluímos tratar-se de técnica cirúrgica segura, de fácil execução e com ótimo resultado estético. Não ocorreram complicações específicas relacionadas ao acesso cirúrgico.<br>A better cosmetic effect may result from minimally invasive techniques available for the surgical correction of congenital cardiopathies. Amongst the possible accesses for the correction of an interatrial communication, we selected a partial sternotomy which we performed in 20 pediatric patients. When analyzed, this group of patients demonstrated that this approach is a safe and easy one, and that the cosmetic result is very satisfactory. No complications specifically related to the surgical access were observed

Upstream clopidogrel, prasugrel, or ticagrelor for patients treated with primary angioplasty: Results of an angiographic randomized pilot study.

OBJETIVES The main objective of the present randomized pilot study was to explore the effects of upstream prasugrel or ticagrelor or clopidogrel for patients with ST-segment-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). BACKGROUND Administration of clopidogrel "as soon as possible" has been advocated for STEMI. Pretreatment with prasugrel and ticagrelor may improve reperfusion. Currently, the angiographic effects of upstream administration of these agents are poorly understood. METHODS A total of 132 patients with STEMI within the first 12 hr of chest pain referred to primary angioplasty were randomized to upstream clopidogrel (600 mg), prasugrel (60 mg), or ticagrelor (180 mg) while still in the emergency room. All patients underwent protocol-mandated thrombus aspiration. RESULTS Macroscopic thrombus material was retrieved in 79.5% of the clopidogrel group, 65.9% of the prasugrel group, and 54.3% of the ticagrelor group (P = 0.041). At baseline angiography, large thrombus burden was 97.7% vs. 87.8% vs. 80.4% in the clopidogrel, prasugrel, and ticagrelor groups, respectively (P = 0.036). Also, at baseline, 97.7% presented with an occluded target vessel in the clopidogrel group, 87.8% in the prasugrel group and 78.3% in the ticagrelor group (P = 0.019). At the end of the procedure, the percentages of patients with combined TIMI grade III flow and myocardial blush grade III were 52.3% for clopidogrel, 80.5% for prasugrel, and 67.4% for ticagrelor (P = 0.022). CONCLUSIONS In patients with STEMI undergoing primary PCI within 12 hr, upstream clopidogrel, prasugrel or ticagrelor have varying angiographic findings, with a trend toward better results for the latter two agents. © 2015 Wiley Periodicals, Inc